New research from Hong Kong examines the effectiveness of schizophrenia treatment approaches by comparing the clinical impacts of long-acting injectable antipsychotics (LAIAs) versus oral antipsychotics. In an analysis of more than 70,000 Chinese individuals with schizophrenia, researchers found that LAIAs were associated with 48% fewer hospitalizations for psychiatric disorders, 47% fewer hospitalizations for schizophrenia, 44% fewer suicide attempts, and 37% fewer hospitalizations overall. Further analysis also showed that individuals who began treatment with LAIAs sooner in the course of illness experienced improved outcomes compared to those who began treatment with LAIAs later on. While further research is needed, LAIAs continue to show promise as an effective treatment approach for schizophrenia. To learn more, see the study in JAMA Psychiatry.